Phase III Study of Afatinib or Cisplatin Plus Pemetrexed in Patients With Metastatic Lung Adenocarcinoma With EGFR Mutations
暂无分享，去创建一个
Jie Yang | L. Sequist | K. O'Byrne | M. Schuler | W. Su | V. Zazulina | N. Yamamoto | V. Hirsh | M. Boyer | V. Gorbunova | K. Lee | J. Bennouna | T. Kato | M. Shahidi | Sarayut Lucien Geater | D. Massey | S. Orlov | R. Shah | T. Mok | C. Tsai